🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label, multi-center, randomized, phase III study. It is aim...
Status
Active Not Recruiting
Location
Guangdong Lung cancer institute
Start Date
2022-06-20
Trial ID
NCT04841811
Treatments Being Tested
The purpose of this study is to test feasibility, toxicity and efficacy of ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2003-09
Trial ID
NCT00490659
Treatments Being Tested
To assess the efficacy and safety of sunvozertinib versus placebo as adjuva...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-12-01
Trial ID
NCT07182682
Treatments Being Tested
The purpose of this study is to determine if radical radiochemotherapy on t...
Status
Terminated
Location
Department of Pneumology RHMS Hôpital de la Madeleine
Start Date
2007-01
Trial ID
NCT00661011
Treatments Being Tested
The use of advanced technological tools able to exploit patient-centered "R...
Status
Unknown
Location
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Start Date
2021-09-28
Trial ID
NCT05815472
Treatments Being Tested
This study is a multicenter, prospective, and observational clinical study ...
Status
Recruiting
Location
Liaoning Cancer Hospital & Institute
Start Date
2024-03-21
Trial ID
NCT06109454
Treatments Being Tested
Progastrin is a pro-hormone that, in physiological conditions, is maturated...
Status
Recruiting
Location
Service de NEURO-ONCOLOGIE du Groupement Hospitalier EST
Start Date
2018-12-04
Trial ID
NCT03787056
Treatments Being Tested
This is a Phase II, single-arm, open-label, multicenter clinical study aime...
Status
Not Yet Recruiting
Location
Beijing Cancer Hospital
Start Date
2025-10-01
Trial ID
NCT07182708
Treatments Being Tested
In this study, the "Curve of Intraoperative Body Temperature Change in Pati...
Status
Completed
Location
2nd Affiliated Hospital
Start Date
2020-01-01
Trial ID
NCT04931589
To determine the optimal objective response rate (ORR) of tislelizumab comb...
Status
Active Not Recruiting
Location
The First Affiliated Hospital of Guangzhou Medical University
Start Date
2020-11-06
Trial ID
NCT07638878
Treatments Being Tested